企業一覧に戻る

COGNIZANT TECHNOLOGY SOLUTIONS CORPCTSH)の決算・業績分析

COGNIZANT TECHNOLOGY SOLUTIONS CORPの2025年有価証券報告書をAI分析。売上高$21.1B(+7.0%)。営業利益$3.4B。Information Technology

目次
SUMMARY — 業績サマリー

COGNIZANT TECHNOLOGY SOLUTIONS CORP2025年度 業績サマリー

COGNIZANT TECHNOLOGY SOLUTIONS CORP(証券コード: CTSH)の2025年度決算・業績分析。売上高は$21.1B(前年比+7.0%)。営業利益は$3.4B(前年比+17.2%)。純利益は$2.2B(前年比-0.4%)。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。

COGNIZANT TECHNOLOGY SOLUTIONS CORP2024年度 注目ポイント

※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。

  1. CTSH achieved $19.4B revenue (+5.0% YoY) and $2.3B net income (+7.2% YoY) in FY2024, driven by acquisitions and Health Sciences segment growth (XBRL).
  2. Operating margin remained stable at 15.3%, with EBITDA at $3.5B (18.2%) and net margin at 11.8% (XBRL).
  3. Strong financial health: 64.9% equity ratio, 0.44x debt-to-equity, and net debt of -$2.0B (XBRL).
  4. Shareholders received $2.0B in returns via $564M dividends and $1.4B share repurchases (XBRL).

COGNIZANT TECHNOLOGY SOLUTIONS CORPの売上高変化の要因

  • Total revenue reached $19.4B (+5.0% YoY), driven by acquisitions (200 bps) and Health Sciences segment growth, partially offset by declines in Products and Resources and Financial Services segments (10-K). Segment-specific revenue figures are not disclosed (N/A). Historical data shows revenue growth from $16.1B (FY2020) to $19.4B (FY2024), with a dip in FY2022 ($16.7B).

COGNIZANT TECHNOLOGY SOLUTIONS CORPの営業利益変化の要因

  • Operating income rose to $3.0B (+5.0% YoY) with a 15.3% margin, supported by NextGen program savings and foreign exchange benefits (10-K). Net income increased to $2.3B (+7.2% YoY) with an 11.8% margin. EBITDA reached $3.5B (18.2%) (XBRL). Gross profit and gross margin data are not available (N/A).

COGNIZANT TECHNOLOGY SOLUTIONS CORPの事業リスクと対応

Economic/geopolitical conditions may reduce client spending and payment reliability (10-K).

Intense competition and rapid technological changes threaten service differentiation (10-K).

Reliance on U.S./Europe clients exposes the company to regional economic downturns (10-K).

Operational risks in India due to inflation, currency volatility, and policy changes (10-K).

Regulatory/legal changes in India and other countries could disrupt operations or increase costs (10-K).

COGNIZANT TECHNOLOGY SOLUTIONS CORPの今後の見通し・業績予想

Management expects continued client focus on AI and digital transformation but did not provide specific financial guidance for FY2025 (10-K). Key trends include AI adoption, client digital transformation, and macroeconomic uncertainties. The NextGen program's cost savings and attrition rates (15.9% voluntary attrition in Tech Services) are highlighted as factors impacting future results (10-K).

COGNIZANT TECHNOLOGY SOLUTIONS CORPの事業内容

Cognizant Technology Solutions Corp (CTSH) provides professional services in digital transformation, consulting, application development, and business process automation, targeting industries like healthcare, financial services, and technology (10-K). Key segments include Health Sciences, Financial Services, Products and Resources, and Communications, Media and Technology. Competitive advantages include AI capabilities, a global delivery model, strategic acquisitions (e.g., Belcan, Thirdera), and partnerships with hyperscalers (10-K).

COGNIZANT TECHNOLOGY SOLUTIONS CORPのAI業績分析レポート(2024年度)

Cognizant Technology Solutions Corp (CTSH) FY2024 Annual Report Analysis

Highlights
Revenue: $19.4B (+5.0% YoY), driven by acquisitions and Health Sciences growth (XBRL).
Profitability: Operating margin 15.3%, net margin 11.8%, EBITDA $3.5B (18.2%) (XBRL).
Financial Health: 64.9% equity ratio, net debt of -$2.0B, and $2.6B in cash (XBRL).
Shareholder Returns: $2.0B returned via dividends ($564M) and buybacks ($1.4B) (XBRL).
Business Overview

Cognizant provides professional services in digital transformation, consulting, application development, and business process automation, targeting healthcare, financial services, and technology sectors. Competitive advantages include AI capabilities, global delivery models, and strategic acquisitions (10-K). Key segments are Health Sciences, Financial Services, Products and Resources, and Communications, Media and Technology (10-K).

Revenue Analysis

Total revenue reached $19.4B (+5.0% YoY), with Health Sciences growth offsetting declines in Products and Resources and Financial Services (10-K). Segment-specific revenue figures are not disclosed (N/A). Historical data shows revenue growth from $16.1B (FY2020) to $19.4B (FY2024), with a dip in FY2022 ($16.7B).

Profitability Analysis

Operating income rose to $3.0B (+5.0% YoY) with a 15.3% margin, supported by NextGen program savings and foreign exchange benefits (10-K). Net income increased to $2.3B (+7.2% YoY) with an 11.8% margin. EBITDA reached $3.5B (18.2%) (XBRL). Gross profit and gross margin data are not available (N/A).

Balance Sheet Analysis

Total assets grew to $18.5B (FY2024), with total equity at $12.0B (XBRL). The company maintains a strong liquidity position with $2.6B in cash and a 2.25x current ratio. Net debt is -$2.0B (-0.6x EBITDA), and long-term debt is $606M (XBRL). Equity ratio is 64.9%, and debt-to-equity is 0.44x (XBRL).

Cash Flow Analysis

Operating cash flow was $2.6B, with free cash flow (FCF) of $2.2B (OCF $2.6B - CapEx $332M) (XBRL). Investing cash flow was -$106M, and financing cash flow was -$1.9B, reflecting $564M in dividends and $1.4B in share repurchases (XBRL).

Working Capital Analysis

Receivables Days: 72 days; Payables Days: 6 days (XBRL). Asset Turnover: 1.05x (XBRL). Cash Conversion Cycle (CCC) data is not available (N/A).

Risks
1.Economic/geopolitical conditions may reduce client spending and payment reliability (10-K).
2.Intense competition and rapid technological changes threaten service differentiation (10-K).
3.Reliance on U.S./Europe clients exposes the company to regional economic downturns (10-K).
4.Operational risks in India due to inflation, currency volatility, and policy changes (10-K).
5.Regulatory/legal changes in India and other countries could disrupt operations or increase costs (10-K).
Outlook

Management expects continued client focus on AI and digital transformation but did not provide specific financial guidance for FY2025 (10-K). Key trends include AI adoption, client digital transformation, and macroeconomic uncertainties. The NextGen program's cost savings and attrition rates (15.9% voluntary attrition in Tech Services) are highlighted as factors impacting future results (10-K).

Historical Time Series
MetricFY2020FY2021FY2022FY2023FY2024FY2025
Revenue16.1B16.8B16.7B18.5B19.4B19.4B
Operating Income2.8B2.5B2.1B2.8B3.0B2.7B
Net Income2.1B1.8B1.4B2.1B2.3B2.1B
Total Assets16.2B16.9B17.9B17.9B18.5B20.0B
Total Equity10.7B11.4B11.0B10.8B12.0B12.3B
Operating Cash Flow2.6B2.5B3.3B2.5B2.6B2.3B

Information Technologyの企業一覧

COGNIZANT TECHNOLOGY SOLUTIONS CORPと同じ「Information Technology」セクターの企業